Rising US scrutiny on clinical trials could threaten China’s biotech advantage: analysts
--------------------------------------------------------------------
Source: South China Morning Post
Published: 2026-09-23 12:00 UTC+10:00
Section: China
Factuality Score: 92
Opinion Category: Neutral
Topics: Business, Asia, China, Business & Economy, Asia Pacific
--------------------------------------------------------------------
Snippet:
China’s ability to conduct clinical trials quickly and cheaply has given it an edge in the biotech sector – and the US is growing concerned
--------------------------------------------------------------------